ArticleCancers2020

The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis.

Normann Steiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.